Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims The use of insulin lispro in pregnancy has not been systematically investigated despite its increasing use. Pooled data from seven centres with experience in the use of insulin lispro were accumulated to evaluate pregnancy outcome in women with Type 1 diabetes. Methods Seven units with specialist obstetric diabetes services were recruited to describe their total experience with insulin lispro in pregnancy. Outcomes with respect to the rate of miscarriage, congenital abnormality, perinatal mortality and maternal parameters were recorded in a standardized format. Results Outcomes on 71 babies from 76 pregnancies were documented. There were six (7.8%) early miscarriages. All 71 babies were liveborn with a mean gestational age of 37.2 weeks, and median birthweight of 3230 g. Seven babies weighed > 4 kg. There were four congenital abnormalities (5.6%). There was a 72% increase in the mean insulin dose (0.75–1.29 IU/kg per day). Maternal glycaemic control improved throughout pregnancy. No women developed retinopathy de novo during pregnancy and six with established retinopathy required laser therapy during pregnancy. Conclusions The use of insulin lispro in Type 1 diabetes during pregnancy results in outcomes comparable to other large studies of diabetic pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Hawthorne, G., Robson, S., Ryall, E. A., Sen, D., Roberts, S. H., & Platt, M. P. W. (1997) · BMJ · doi:10.1136/bmj.315.7103.279 · Cited by 276
Buchbinder, A., Miodovnik, M., McElvy, S., Rosenn, B., Kranias, G., Khoury, J., & Siddiqi, T. A. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108893 · Cited by 51
Persson, B., & Hansson, U. (1993) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80216-2 · Cited by 30
Research works printed but not linked: 26
- 10.1016/0002-9378(72)90118-4 · DOI · Paper page
- 10.1136/bmj.315.7103.275 · DOI · Paper page
- 10.1016/0002-9378(90)91184-E · DOI · Paper page
- 10.1056/NEJM199710023371414 · DOI
- 10.2337/diacare.22.5.874 · DOI
- 10.1056/NEJM199804163381607 · DOI · Paper page
- 10.1136/bmj.317.7171.1503 · DOI
- 1976, Thalidomide's long shadow, BMJ, 1155
- Anderson JH, 1997, Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin‐analog treatment: Multicenter Insulin Lispro Study Group, Diabetes, 46, 265, 10.2337/diab.46.2.265 · DOI · Paper page
- 10.2337/diacare.22.10.1607 · DOI · Paper page
- 10.2337/diacare.22.7.1226 · DOI
- 10.3109/07853899809005853 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1016/S0002-9378(87)80378-2 · DOI
- Idama T, 1999, Comparison of glucose excursions following insulin lispro given before or after meals in pregnant diabetics, J Obstet Gynaecol, 19, 58
- 10.2337/diacare.21.4.570 · DOI · Paper page
- 10.2337/diacare.22.5.846 · DOI
- 10.2337/diacare.22.12.2101 · DOI
- 10.1016/S0095-5108(18)30089-7 · DOI
- Hadden DR, 1999, How to improve prognosis in Type 1 diabetic pregnancy, Diabetes Care, 22, B104
- 10.1002/(SICI)1096-9136(199606)13:6<589::AID-DIA106>3.0.CO;2-P · DOI
- 10.1210/jcem-40-1-139 · doi:10.1210/jcem-40-1-139
- 10.1056/NEJM199008023230505 · DOI · Paper page
- 10.2337/diacare.22.9.1422 · DOI · Paper page
- 10.1136/bmj.319.7219.1223 · DOI · Paper page
- Evers IM, 2000, Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control. [Dutch], Nederlands Tijdschrift voor Geneeskunde, 144, 804
Cited by
Hirsch, I. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040832 · Cited by 667
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Masson, E. A., Patmore, J. E., Brash, P. D., Baxter, M., Caldwell, G., Gallen, I. W., Price, P. A., Vice, P. A., Walker, J. D., & Lindow, S. W.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 20
- Issue
- 1
- Pages
- 46-50
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1993588231
- Cited by
- 66
- References
- 5
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). https://app.cochat.ai/papers/10.1046/j.1464-5491.2003.00840.x
- The paper
- Masson, E. A., Patmore, J. E., Brash, P. D., Baxter, M., Caldwell, G., Gallen, I. W., Price, P. A., Vice, P. A., Walker, J. D., & Lindow, S. W. (2003). Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2003.00840.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.